Evidence map›Paper›PMID 32419040›Full record

ArticleCVIR endovascular2020

Spanish multicenter real - life registry of retrievable vena cava filters (REFiVeC).

Miguel A De Gregorio, Jose A Guirola, Jose Urbano, Ignacio Díaz-Lorenzo, Jose J Muñoz, Elena Villacastin, Antonio Lopez-Medina, Ana L Figueredo, Javier Guerrero, Sergio Sierre and 3 more

Abstract read
In one paragraph

Article in CVIR endovascular, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Inferior Vena Cava Filter Retrieval Trends: A Single-Center Experience.TH open : companion journal to thrombosis and haemostasis · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Miguel A De GregorioHospital Universitario Lozano Blesa, Universidad de Zaragoza, Zaragoza, Spain. mgregori@unizar.es.
Jose A GuirolaHospital Universitario Lozano Blesa, Universidad de Zaragoza, Zaragoza, Spain.
Jose UrbanoHospitales Vithas, Madrid, Spain.
Ignacio Díaz-LorenzoHospital Universitario La Princesa, Madrid, Spain.
Jose J MuñozHospital Universitario Carlos Haya, Malaga, Spain.
Elena VillacastinHospital Rio Hortega, Valladolid, Spain.
Antonio Lopez-MedinaHospital de Basurto Hospital, Bilbao, Spain.
Ana L FigueredoHospital Universitario Miguel Servet, Zaragoza, Spain.
Javier GuerreroGrupo Investigación Técnicas Mínimamente Invasivas (GITMI), Zaragoza, Spain.
Sergio SierreHospital Universitario Austral, Buenos Aires, Argentina.
Javier Blazquez SanchezHospital Ramón y Cajal, Madrid, Spain.
William T KuoDepartment of Radiology, Stanford University Medical Center, Stanford, CA, USA.
David JimenezHospital Ramón y Cajal and Universidad de Alcalá (IRYCIS), Madrid, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe treatment of venous thromboembolic disease the treatment of choice is systemic anticoagulation. However, the interruption of the inferior vena cava with filters has been recommended when anticoagulation fails or there is a contraindication. Due to the rising inferior vena cava filter (IVCF) complications, physicians are encouraged to retrieve them when there is no longer recommended. In daily practice, it may be a difficult close follow-up of these patients. In this study, the primary objective was to evaluate the IVCF retrieval rate of all implanted filters in a Spanish registry. Secondary objectives were to analyze the causes of failed retrieval, procedure-related complications, and outcomes at a 12-month follow-up.

resultsThree hundred fifty-six vena cava filters were implanted in 355 patients. The types of filter were: Gunther Tulip (Cook Medical) 160 (44.9%), Optease (Cordis) 77 (21.6%), Celect (Cook Medical) 49 (13, 7%), Aegisy (Lifetech Scientific) 33 (9.2%), Option ELITE (Argon Medical devices) 16 (4.4%), Denali filter (BD Bard) 11 (3.08%), ALN filter (ALN) 10 (2.8%). Removal was achieved in 274/356 (76,9%). eighty-two (23,1%) IVCF were not retrieved due to the following: 41 (11,5%) patients required ongoing filtration, 24 IVCF (6,7%) patients died before retrieval, and 17 (4,7%) impossibility of retrieval because of a tilted and embedded filter apex. There were no major complications observed.

conclusionsThe global retrieval rate of IVCF was achieved in 76.9%, and the adjusted retrieval rate was of 94.15% with no major complications. IVCF tilting was associated with failure of filter removal in less than 5% of cases. This study demonstrates that the retrieval procedure of IVCF is controlled by the clinician and not by the interventional radiologist.

Indexed as

Inferior vena cava filtersRetrievable filtersVenous thrombotic disease (VTD)

Identifiers

PMID32419040
PMCPMC7231811

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.